Undisclosed patient death and primate injury in gene therapy preclinical research

A preclinical study involving viral vector brain infusion failed to disclose the death of a human subject and severe adverse effects observed in primates. The omission raises significant ethical and regulatory concerns regarding the transparency of clinical trial reporting and safety protocols in gene therapy development.